Endoscopic Submucosal Dissection Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

ESD is an advanced therapeutic endoscopy technique that enables en bloc resection of superficial gastrointestinal neoplasms, offering higher curative resection rates than conventional EMR. The global market, valued at approximately $0.51 billion in 2025, is forecast to grow at a 6.6% compound annual rate through the early 2030s. Public estimates place the market between roughly $0.62 billion and $0.75 billion by 2030, reflecting strong but variable analyst projections based on differing product scopes and forecast horizons.

• •Estimated 2025 market value: ~$0.51 billion; CAGR ~6.6%
• •Analyst projections for 2030 range from roughly $0.62 billion to $0.75 billion
• •ESD enables en bloc resection of early GI cancers with reduced invasiveness versus surgery

Rising global incidence of gastric, esophageal, and colorectal cancers is expanding the eligible patient pool for endoscopic resection. Healthcare systems are shifting toward minimally invasive, organ-preserving treatments that reduce hospital stays and overall cost of care. Improvements in device design, including electrosurgical knives, injection solutions, and traction accessories, are also lowering technical barriers and shortening learning curves for endoscopists.

• •Growing burden of early-stage GI cancers detected through screening programs
• •Increasing preference for minimally invasive, organ-preserving procedures
• •Device innovation reducing procedure complexity and operator learning curve

The market is commonly segmented by product (knives, injection agents, graspers, electrosurgical generators, and accessories), indication (gastric, colorectal, esophageal), and end user (hospitals, ambulatory surgical centers, specialty clinics). Asia-Pacific dominates global volume due to high gastric cancer rates in Japan, South Korea, and China and decades-long reimbursement and training support for ESD. North America and Europe are smaller but faster-growing in relative terms, supported by expanding colorectal ESD adoption and updated clinical guidelines.

• •Product segment: electrosurgical knives and injection solutions account for the largest share
• •Asia-Pacific leads global revenue and procedure volume; North America and Europe are growth markets
• •Colorectal ESD is the fastest-growing indication segment outside Asia

What are the recent trends and outlook?

Training programs and AI-assisted lesion characterization are expanding the pool of endoscopists competent in ESD, particularly in Western markets. Hybrid techniques such as laparoscopic-endoscopic cooperative surgery and underwater ESD are gaining traction for complex lesions. Over the forecast horizon, procedure volumes are expected to keep climbing as colorectal ESD indications broaden and reimbursement frameworks mature, sustaining mid-single-digit annual growth through 2030 and beyond.

• •AI-enabled lesion detection and robotics-assisted endoscopy are emerging trends
• •Colorectal and esophageal ESD indications continue to broaden clinically
• •Long-term growth supported by expanding reimbursement and standardized training